查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1935509

近距離放射治療全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Brachytherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計近距離放射治療市場將從 2025 年的 11.7 億美元成長到 2034 年的 22.9 億美元，2026 年至 2034 年的複合年成長率為 7.72%。

受癌症患者數量不斷增加和對標靶治療需求日益成長的推動，近距離放射治療市場正經歷顯著成長。近距離放射治療是一種將放射性物質直接輸送到腫瘤內部或附近的放射治療方法，與傳統的體外放射治療相比，具有許多優勢，包括減少周圍正常組織的輻射暴露和提高治療精度。隨著醫療機構尋求改善患者預後並最大限度地減少副作用，預計近距離放射治療的應用將會增加，從而推動該市場的強勁成長。越來越多的臨床證據支持近距離放射治療在治療包括前列腺癌、乳癌和子宮頸癌在內的多種癌症方面的療效，進一步佐證了這一趨勢。

此外，近距離放射治療技術的進步正在推動市場創新。新型放射性同位素的研發、改良的輸送系統以及先進的影像技術的出現，提高了近距離放射治療的有效性和安全性。這些創新不僅改善了治療效果，也有助於簡化醫療專業人員的工作流程。隨著對近距離放射治療新應用（例如與免疫療法和其他治療方法聯合使用）的研究不斷深入，預計該市場將進一步擴張，因為它有望改善患者照護效果。

此外，對個人化醫療的日益重視正在重塑近距離放射治療的格局。隨著醫療服務提供者越來越傾向於根據個別患者的情況調整治療方案，對靈活且適應性強的近距離放射治療解決方案的需求預計將會成長。這一趨勢在晚期癌症治療領域尤其重要，因為了解腫瘤的特定特徵會顯著影響治療決策。隨著近距離放射治療市場的不斷發展，技術創新、個人化治療方法以及對改善患者預後的關注將共同推動未來的成長。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球近距離放射治療市場（依劑型分類）

  • 市場分析、洞察與預測
  • 高劑量率（HDR）近距離放射治療
  • 低劑量率（LDR）近距離放射治療

5. 全球近距離放射治療市場（依產品分類）

  • 市場分析、洞察與預測
  • 種子
  • 施用器和後荷機
  • 電子束近距離放射治療

6. 全球近距離放射治療市場（依應用分類）

  • 市場分析、洞察與預測
  • 攝護腺癌
  • 婦科癌症
  • 乳癌
  • 其他

7. 全球近距離放射治療市場（依地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Varian Medical Systems Inc
    • Becton
    • Dickinson & Company
    • Elekta AB
    • Isoray Medical Inc
    • Eckert & Ziegler BEBIG
    • ICAD Inc
    • CIVCO Medical Solutions
    • Theragenics Corporation
簡介目錄
Product Code: VMR11211002

The Brachytherapy Market size is expected to reach USD 2.29 Billion in 2034 from USD 1.17 Billion (2025) growing at a CAGR of 7.72% during 2026-2034.

The brachytherapy market is experiencing significant growth, driven by the increasing prevalence of cancer and the demand for targeted treatment options. Brachytherapy, a form of radiation therapy that involves placing radioactive sources directly within or near a tumor, offers several advantages over traditional external beam radiation therapy, including reduced exposure to surrounding healthy tissues and improved treatment precision. As healthcare providers seek to enhance patient outcomes and minimize side effects, the adoption of brachytherapy is expected to rise, positioning this market for robust expansion. The growing body of clinical evidence supporting the efficacy of brachytherapy in treating various cancers, including prostate, breast, and cervical cancers, is further fueling this trend.

Moreover, advancements in brachytherapy technologies are driving innovation within the market. The development of new radioactive isotopes, improved delivery systems, and advanced imaging techniques is enhancing the effectiveness and safety of brachytherapy procedures. These innovations not only improve treatment outcomes but also contribute to a more streamlined workflow for healthcare providers. As research continues to explore new applications for brachytherapy, such as in combination with immunotherapy and other treatment modalities, the market is likely to expand further, driven by the promise of improved patient care and outcomes.

Additionally, the growing emphasis on personalized medicine is shaping the brachytherapy landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable brachytherapy solutions is likely to rise. This trend is particularly relevant in the context of advanced cancer treatments, where understanding the specific characteristics of a tumor can significantly impact treatment decisions. As the brachytherapy market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Dosage Type

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

By Product

  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy

By Application

  • Prostate Cancer
  • Gynaecological Cancer
  • Breast Cancer
  • Others

COMPANIES PROFILED

  • Varian Medical Systems Inc, Becton, Dickinson Company, Elekta AB, Isoray Medical Inc, Eckert Ziegler BEBIG, iCAD Inc, CIVCO Medical Solutions, Theragenics Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BRACHYTHERAPY MARKET: BY DOSAGE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Dosage Type
  • 4.2. High-Dose Rate (HDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Low-Dose Rate (LDR) Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BRACHYTHERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Seeds Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Applicators & Afterloaders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Electronic Brachytherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BRACHYTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Gynaecological Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BRACHYTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Dosage Type
    • 7.2.2 By Product
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Dosage Type
    • 7.3.2 By Product
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Dosage Type
    • 7.4.2 By Product
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Dosage Type
    • 7.5.2 By Product
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Dosage Type
    • 7.6.2 By Product
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BRACHYTHERAPY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Varian Medical Systems Inc
    • 9.2.2 Becton
    • 9.2.3 Dickinson & Company
    • 9.2.4 Elekta AB
    • 9.2.5 Isoray Medical Inc
    • 9.2.6 Eckert & Ziegler BEBIG
    • 9.2.7 ICAD Inc
    • 9.2.8 CIVCO Medical Solutions
    • 9.2.9 Theragenics Corporation